Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Cancers|December 11, 2022
ERK MAP Kinase Signaling Regulates RAR Signaling to Confer Retinoid Resistance on Breast Cancer CellsAkira Hirota, Jean-Emmanuel Clément, Satoshi Tanikawa, et al.
Journal of Glaucoma|May 19, 2026
Outcomes of Ahmed Glaucoma Valve Implantation in the Ciliary Sulcus Versus the Anterior ChamberKohei Kuroda, Yusuke Hayashi, Satoko Asaoka, et al.
Case Reports in Oncology|April 30, 2025
Excellent Response to Trastuzumab Deruxtecan of a Large Medullary Metastasis from Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Case ReportAoi Kuroda, Mao Uematsu, Mai Shimura, et al.
The Oncologist|March 14, 2026
Impact of everolimus-related interstitial lung disease on subsequent treatment in patients with metastatic breast cancerHikari Kiyohara, Chihiro Kondoh, Akira Hirota, et al.
Cell Reports|February 14, 2025
The balance between IFN-γ and ERK/MAPK signaling activities ensures lifelong maintenance of intestinal stem cellsMay Nakajima-Koyama, Mio Kabata, Joonseong Lee, et al.
Melanoma Research|September 11, 2023
Safety of immune checkpoint inhibitors after proton beam therapy in head and neck mucosal melanoma: a case seriesMao Uematsu, Hiromichi Nakajima, Ako Hosono, et al.
The Oncologist|April 25, 2026
Efficacy of perioperative pembrolizumab for triple-negative breast cancer with apocrine feature or metaplastic carcinomaNobuyuki Takahashi, Chikako Funasaka, Mai Shimura, et al.
Scientific Reports|February 14, 2023
Engineering of an electrically charged hydrogel implanted into a traumatic brain injury model for stepwise neuronal tissue reconstructionSatoshi Tanikawa, Yuki Ebisu, Tomáš Sedlačík, et al.
Frontiers in Oncology|June 18, 2026
Clinical benefit of paclitaxel/carboplatin plus bevacizumab with zoledronic acid in pulmonary epithelioid hemangioendothelioma complicated by hypertrophic pulmonary osteoarthropathy and cardiac tamponade: a case reportSaki Tsuchimochi, Hiromichi Nakajima, Yukako Hattori, et al.
Cancer Medicine|March 27, 2025
The Impact of Carboplatin Dosing Design Using Adjusted Serum Creatinine on Carboplatin Plus Paclitaxel Therapy for Ovarian CancerShu Kato, Kaede Baba, Kanako Mamishin, et al.
Pageof 5